相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancer
Shin Il Kim et al.
PANCREATOLOGY (2017)
Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer
Akira Chikamoto et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer
Jose M. Pimiento et al.
CLINICAL NUCLEAR MEDICINE (2016)
Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study
John R. Bergquist et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2016)
CT Imaging Biomarkers Predict Clinical Outcomes After Pancreatic Cancer Surgery
Liang Zhu et al.
MEDICINE (2016)
Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma
Ashley H. Davis-Yadley et al.
PANCREAS (2016)
Prognostic impact of carcinoembryonic antigen (CEA) on patients with metastatic pancreatic cancer: A retrospective cohort study
Hiroshi Imaoka et al.
PANCREATOLOGY (2016)
Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care
Stephanie T. Chang et al.
RADIOLOGY (2016)
DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin
Xilin Sun et al.
PLOS ONE (2016)
Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer
Si-Liang Wang et al.
ABDOMINAL IMAGING (2015)
Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy
Yu-Lei Gu et al.
Asian Pacific Journal of Cancer Prevention (2015)
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer
Hideaki Kinugasa et al.
CANCER (2015)
Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer
Si Shi et al.
CANCER LETTERS (2015)
Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma
Shuhei Komatsu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Genomic change index (GCI) and liquid biopsies in predicting and monitoring response to therapy in advanced pancreatic ductal adenocarcinoma (PDAC)
Madappa N. Kundranda et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer
Daniel Reitz et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
Jaihwan Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions
Paul F. Laeseke et al.
RADIOLOGY (2015)
Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications
John Chang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
Monika Bauden et al.
CLINICAL EPIGENETICS (2015)
A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer
Liang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Preoperative CA 19-9 Kinetics as a Prognostic Variable in Radiographically Resectable Pancreatic Adenocarcinoma
Erin G. Brown et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
Faruk Tas et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Contrast-enhanced CT and diffusion-weighted MR imaging: Performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma
Yoshihiko Fukukura et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Elevated serum CA 19-9 at screening tests: underlying conditions and role of abdominopelvic CT
Ji Yang Kim et al.
EUROPEAN RADIOLOGY (2014)
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Nicolai A. Schultz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Eugene J. Koay et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels
Ming-Chu Chang et al.
PANCREATOLOGY (2014)
Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study
Brian M. Nolen et al.
PLOS ONE (2014)
Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments
Irene Esposito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy
Christin Wittwer et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy
Michael Haas et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - A retrospective tumor marker prognostic study
Marius Distler et al.
INTERNATIONAL JOURNAL OF SURGERY (2013)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Small and Potentially Resectable Focal Pancreatic Lesions Noted on CT/MRI Scans in Nonjaundiced Patients: Likelihood of Neoplasia and Utility of EUS
Naveen B. Krishna et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Whole Blood DNA Aberrant Methylation in Pancreatic Adenocarcinoma Shows Association with the Course of the Disease: A Pilot Study
Albertas Dauksa et al.
PLOS ONE (2012)
Serum Biomarker Panels for the Detection of Pancreatic Cancer
Randall E. Brand et al.
CLINICAL CANCER RESEARCH (2011)
The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro
Ling Zhang et al.
MOLECULAR BIOLOGY REPORTS (2011)
Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls
Katrina S. Pedersen et al.
PLOS ONE (2011)
Diagnostic Usefulness of Serum Interleukin 6 (IL-6) and C-Reactive Protein (CRP) in the Differentiation Between Pancreatic Cancer and Chronic Pancreatitis
Barbara Mroczko et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2010)
Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy
T. Niwa et al.
BRITISH JOURNAL OF RADIOLOGY (2009)
Indicative findings of pancreatic cancer in prediagnostic CT
Sung Soo Ahn et al.
EUROPEAN RADIOLOGY (2009)
EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics
Naveen B. Krishna et al.
GASTROINTESTINAL ENDOSCOPY (2009)
CEA and CA-19.9 Serum Tumor Markers as Prognostic Factors in Patients with Locally Advanced (Unresectable) or Metastatic Pancreatic Adenocarcinoma: A Retrospective Analysis
N. Tsavaris et al.
JOURNAL OF CHEMOTHERAPY (2009)
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Marilena V. Iorio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis
Stephanie T. Chang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: Correlation with angiogenesis and fibrosis
Yuki Hattori et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant MicroRNA expression
Olga Kovalchuk et al.
CELL CYCLE (2007)
Validation of the 6th Edition AJCC Pancreatic Cancer Staging System - Report from the National Cancer Database
Karl Y. Bilimoria et al.
CANCER (2007)
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
K. S. Goonetilleke et al.
EJSO (2007)
The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer
Seungmin Bang et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis
DA Tessler et al.
AMERICAN JOURNAL OF SURGERY (2006)
Molecular markers of early pancreatic cancer
M Goggins
JOURNAL OF CLINICAL ONCOLOGY (2005)
Nucleosomes in pancreatic cancer patients during radiochemotherapy
A Kremer et al.
TUMOR BIOLOGY (2005)
Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: Retrospective review of CT scans obtained before diagnosis
S Gangi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2004)
Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population
JE Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma
ZQ Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)